The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Former Covidien (NYSE:COV) president & CEO Richard Meelia decided not to stand for re-election as chairman of the med-tech maker’s board.
Meelia agreed to serve as a non-executive chairman of the Mansfield, Mass-based med-tech titan for a year after his retirement last July.
Amid celebrating the first human use of its Symphony implantable heart pump for chronic heart failure patients, Abiomed (NSDQ:ABMD) unveiled a new ventricular assist device for its flagship Impella line of heart pumps.
Announced at the company’s annual investors’ day in New York, the new device is slated to hit the market some time next summer. Abiomed also has its sights set on entering the Japanese market in 2013.
Shares of Smith & Nephew (NYSE:SNN) slipped initially but have regained some of their value since more talk of a possible buyout surfaced in the U.K. last week.
The British orthopedics giant is up 2.7 percent on The Street today to $43.94 after flirting with a 52-week low Friday, Nov. 25. The stock has fared even worse in its home country following an "uninspiring" meeting with analysts last week.
MASSDEVICE ON CALL — Uncertainty surrounding the use of cardiac stents and angioplasty balloons may lead to a market backlash against the devices and their makers.
At least 4 percent and up to 12 percent of percutaneous coronary interventions may be implanted outside of industry-recommended guidelines, according to an article published in the Journal of the American Medical Assn. yesterday.
MASSDEVICE ON CALL — The Mass. Life Sciences Center, a quasi-public agency that oversees state dollars allocated toward increasing the life sciences industry’s footprint in the Bay State, doled out another $3.8 million in “accelerator” loans.
The program is designed to provide a boost to early-stage life science companies that the center’s scientific advisory board deems to have a high potential for commercialization, rapid growth and the ability to raise substantial capital.
Abbott Laboratories (NYSE:ABT) will donate more than $3 million to the victims of last week’s disastrous earthquake in Japan through its philanthropic foundation, the company said today.
Accuray Inc. (NSDQ:ARAY) looks set to acquire radiation treatment firm TomoTherapy Inc. (NSDQ:TOMO) in a deal worth $277 million.
The Sunnyvale, Calif.-based radiosurgery company signed an agreement to buy TomoTherapy for $4.80 per share in cash and stock, a nearly 31 percent premium over its $3.67 closing price on Friday, March 4.
The companies believe their technologies complement one another in that they can serve overlapping patient populations.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past few days:
